Seven-Year Treatment Outcome of Entecavir in a Real-World Cohort: Effects on Clinical Parameters, HBsAg and HBcrAg Levels

OBJECTIVES: We aimed to determine the levels of alanine aminotransferase (ALT), hepatitis B virus DNA (HBV DNA), HBsAg, and a novel viral marker (hepatitis B core-related antigen (HBcrAg)); hepatitis B e antigen (HBeAg) seroconversion and drug resistance rates after 7 years of entecavir treatment in...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Yuk-Fai, Seto, Wai-Kay, Wong, Danny, Cheung, Ka-Shing, Fung, James, Mak, Lung-Yi, Yuen, John, Chong, Chun-Kong, Lai, Ching-Lung, Yuen, Man-Fung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666122/
https://www.ncbi.nlm.nih.gov/pubmed/29072673
http://dx.doi.org/10.1038/ctg.2017.51

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666122/
https://www.ncbi.nlm.nih.gov/pubmed/29072673
http://dx.doi.org/10.1038/ctg.2017.51

Ejemplares similares